Climb Bio, Inc. CLYM Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -30.9%+31.1pp | -32.1%+14.1pp | -25.6%+16.4pp | -22.9%+15.4pp | -62%-49.0pp | |
| Liquidity | ||||||
| Current ratio | 27.9×+13.6× | 15.2×-16.3× | 18.4×-39.4× | 14.1×-46.3× | 14.3×-22.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $2.17-24.3% | $2.37-46.2% | $2.60-20.3% | $2.75-62.5% | $2.87-25.5% | |
| Valuation | ||||||
| Market capitalization | $724.95M+787% | $190.98M— | $136.21M— | —— | —— | |
| Price / book | 4.9×+4.5× | 1.2×— | 0.8×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Climb Bio, Inc.'s ratios come from?
- Every ratio is computed from Climb Bio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.